A Comparative Study about the Neuroprotective Effects of EPA-Enriched Phosphoethanolamine Plasmalogen and Phosphatidylethanolamine Against Oxidative Damage in Primary Hippocampal Neurons

Zhu Yunfang,Zhang Tiantian,Ding Lin,Shi Haohao,Pilot National Laboratory for Marine Science and Technology (Qingdao),Xie Wancui,Qingdao University of Science and Technology
DOI: https://doi.org/10.1007/s11802-021-4764-6
2021-01-01
Journal of Ocean University of China
Abstract:Oxidative stress is involved in the progression of neurodegenerative diseases. Previous evidences showed that plasmalogens could improve neurodegenerative diseases. In this study, we investigated the function of phosphoethanolamine plasmalogens enriched with EPA(EPA-p PE) and phosphatidylethanolamine enriched with EPA(EPA-PE) on oxidative damage prevention after hydrogen peroxide(H 2 O 2 ) and tert-butylhydroperoxide(t-BHP) challenge in primary hippocampal neurons. Results showed that neurons pretreated with EPA-p PE and EPA-PE demonstrated the ability to alleviate oxidative damage, which was proved by the increased cell viability. Moreover, the shape and number of neurons were more similar to those of the control group. Antioxidant activity, apoptosis, as well as Trk B/ERK/CREB signaling pathway were investigated to explore the mechanisms. The results suggested that EPA-PE was superior to EPA-p PE in regulating mitochondrial apoptosis. EPA-p PE was more prominent than EPA-PE in upregulating Trk B/ERK/CREB signaling pathway. Phospholipids with EPA exerted neuroprotective effects via inhibiting oxidative stress, suppressing apoptosis, and regulating Trk B/ERK/CREB signaling pathway. Therefore, the results provide a scientific basis for utilization of phospholipids enriched with EPA on the treatment of neurodegenerative disease.
What problem does this paper attempt to address?